Disposiciones generales. Consejería de Salud y Consumo. (2022/195-3)
Acuerdo de 4 de octubre de 2022, del Consejo de Gobierno, por el que se toma conocimiento de la Instrucción de la Consejería de Salud y Consumo sobre la Campaña de Vacunación 2022-2023 frente a la gripe y al COVID-19 en Andalucía.
63 páginas totales
Página
Zahoribo únicamente muestra información pública que han sido publicada previamente por organismos oficiales de España.
Cualquier dato, sea personal o no, ya está disponible en internet y con acceso público antes de estar en Zahoribo. Si lo ves aquí primero es simple casualidad.
No ocultamos, cambiamos o tergiversamos la información, simplemente somos un altavoz organizado de los boletines oficiales de España.
Cualquier dato, sea personal o no, ya está disponible en internet y con acceso público antes de estar en Zahoribo. Si lo ves aquí primero es simple casualidad.
No ocultamos, cambiamos o tergiversamos la información, simplemente somos un altavoz organizado de los boletines oficiales de España.
BOJA
Boletín Oficial de la Junta de Andalucía
Número 195 - Lunes, 10 de octubre de 2022
página 15715/59
CONS������ �� S��U� � CONSUMO
�irecci�n �eneral de Salud ���lica � �rdenaci�n �ar�ac�u�ica
Servicio Andaluz de Salud
INSTRUCCIÓN DGSPYOF-9/2022 - VACUNACION ANTIGRIPAL ANDALUCIA 2022-2023
Depósito Legal: SE-410/1979. ISSN: 2253 - 802X
56
http://www.juntadeandalucia.es/eboja
00268981
booster vaccination. medRxiv. 2022 Aug 31;2022.08.30.22279344.
- Cao Y, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature
2022.
- Chang LJ, et al. Safety and Immunogenicity of high-dose quadrivalent influenza vaccine in
adults ≥65 years of age: A phase 3 randomized Clinical trial. Vaccine. 2019;37(39):5825-34.
- DRIVE-WP7-IVE Report. D7.9 Brand-specific influenza vaccine effectiveness in Europe Season
2021/22.
- Flannery B, et al. Influenza vaccine effectiveness against pediatric deaths: 2010-2014.
Pediatrics. 2017;139.pii:e20164244.
- Gonzalez-Rubio F, et al. Influenza vaccination: an ally to mitigate influenza-associated risks
during the coronavirus pandemics. Clin Infect Dis. 2021;72:2249-50.
- Hause AM, et al. Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination in the US. JAMA Netw Open. 2022 Jul 1;5(7): e2222241.
- Iacobucci G. Covid-19: Risk of death more than doubled in people who also had flu, English
data show. BMJ. 2021;370:m3720.
- Lazarus R, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021 Dec
18;398(10318):2277-2287.
- Mattila JM, et al. Burden of influenza during the first year of life. Influenza Other Respi Viruses.
2021;15:506-12.
- Merced-Morales A, et al. Influenza Activity and Composition of the 2022–23 Influenza Vaccine
- United States, 2021–22 Season. MMWR Morb Mortal Wkly Rep. 2022;71:913-19.
- Monge S, et al. Effectiveness of a second dose of a mRNA vaccine against SARS-CoV-2 Omicron
infection in individuals previously infected by other variants. Clin Infect Dis. 2022 Jun
10:ciac429.
- Olson S, et al. Vaccine effectiveness against life-threatening influenza illness in US children. Clin
Infect Dis. 202275(2):230-8.
- Scholz SM, et al. Cost-effectiveness of routine childhood vaccination against seasonal influenza
in Germany. Value Health. 2021;24:32-40.
- Stowe J, et al. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection
on disease severity: a test-negative design. Int J Epidemiol. 2021, 3/may.
DOI:10.1093/ije/dyab081.
- Toback S, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) coadministered with seasonal influenza vaccines. medRxiv. 2021, 13/jun.
- Villani L, et al. Seasonal influenza in children: Costs for the health system and society in Europe
Influenza Other Respir Viruses. 2022;16:820-31.
Boletín Oficial de la Junta de Andalucía
Número 195 - Lunes, 10 de octubre de 2022
página 15715/59
CONS������ �� S��U� � CONSUMO
�irecci�n �eneral de Salud ���lica � �rdenaci�n �ar�ac�u�ica
Servicio Andaluz de Salud
INSTRUCCIÓN DGSPYOF-9/2022 - VACUNACION ANTIGRIPAL ANDALUCIA 2022-2023
Depósito Legal: SE-410/1979. ISSN: 2253 - 802X
56
http://www.juntadeandalucia.es/eboja
00268981
booster vaccination. medRxiv. 2022 Aug 31;2022.08.30.22279344.
- Cao Y, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature
2022.
- Chang LJ, et al. Safety and Immunogenicity of high-dose quadrivalent influenza vaccine in
adults ≥65 years of age: A phase 3 randomized Clinical trial. Vaccine. 2019;37(39):5825-34.
- DRIVE-WP7-IVE Report. D7.9 Brand-specific influenza vaccine effectiveness in Europe Season
2021/22.
- Flannery B, et al. Influenza vaccine effectiveness against pediatric deaths: 2010-2014.
Pediatrics. 2017;139.pii:e20164244.
- Gonzalez-Rubio F, et al. Influenza vaccination: an ally to mitigate influenza-associated risks
during the coronavirus pandemics. Clin Infect Dis. 2021;72:2249-50.
- Hause AM, et al. Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination in the US. JAMA Netw Open. 2022 Jul 1;5(7): e2222241.
- Iacobucci G. Covid-19: Risk of death more than doubled in people who also had flu, English
data show. BMJ. 2021;370:m3720.
- Lazarus R, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021 Dec
18;398(10318):2277-2287.
- Mattila JM, et al. Burden of influenza during the first year of life. Influenza Other Respi Viruses.
2021;15:506-12.
- Merced-Morales A, et al. Influenza Activity and Composition of the 2022–23 Influenza Vaccine
- United States, 2021–22 Season. MMWR Morb Mortal Wkly Rep. 2022;71:913-19.
- Monge S, et al. Effectiveness of a second dose of a mRNA vaccine against SARS-CoV-2 Omicron
infection in individuals previously infected by other variants. Clin Infect Dis. 2022 Jun
10:ciac429.
- Olson S, et al. Vaccine effectiveness against life-threatening influenza illness in US children. Clin
Infect Dis. 202275(2):230-8.
- Scholz SM, et al. Cost-effectiveness of routine childhood vaccination against seasonal influenza
in Germany. Value Health. 2021;24:32-40.
- Stowe J, et al. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection
on disease severity: a test-negative design. Int J Epidemiol. 2021, 3/may.
DOI:10.1093/ije/dyab081.
- Toback S, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) coadministered with seasonal influenza vaccines. medRxiv. 2021, 13/jun.
- Villani L, et al. Seasonal influenza in children: Costs for the health system and society in Europe
Influenza Other Respir Viruses. 2022;16:820-31.
